Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion (Q38324049)

2 September 2017

title

Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion (English)

1 reference

Herpes simplex virus type 1

2 September 2017

1 reference

1 reference

1 reference

5

David T Curiel

1 reference

2 September 2017

Jing Li

1

1 reference

2 September 2017

Long Le

series ordinal

2

1 reference

2 September 2017

Don A Sibley

series ordinal

3

1 reference

2 September 2017

J Michael Mathis

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

2 September 2017

1 reference

2 September 2017

volume

338

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

247-258

1 reference

Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

PET: a revolution in medical imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Optical imaging of Renilla luciferase reporter gene expression in living mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

PET imaging of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Transductional targeting of adenoviral cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Replication-selective oncolytic viruses in the treatment of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

A new method for quantitative determination of tritium-labeled nucleoside kinase products adsorbed on DEAE-cellulose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Transductional and transcriptional targeting of adenovirus for clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Indirect Monitoring of Endogenous Gene Expression by Positron Emission Tomography (PET) Imaging of Reporter Gene Expression in Transgenic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Non-invasive imaging of reporter genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Whole-body FDG-PET imaging in the management of patients with cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Fluorescently labeled adenovirus with pIX-EGFP for vector detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Monitoring adenoviral DNA delivery, using a mutant herpes simplex virus type 1 thymidine kinase gene as a PET reporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Visualizing protein-protein interactions in living animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Targeted adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Adenovirus protein IX: a new look at an old protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

New developments in the virus therapy of cancer: a historical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

An HSV-TK transgenic mouse model to evaluate elimination of fibroblasts for fibrosis therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Influence of the bystander effect on HSV-tk/GCV gene therapy. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Adenoviral vectors for gene transfer and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Small animal PET: aspects of performance assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

Visualizing gene expression by whole-body fluorescence imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.005

10.1016/J.VIROL.2005.04.005

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference